Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
KIF22 |
kinesin family member 22 |
Mapped by CNV |
|
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
Mapped by LD-proxy |
|
MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
ZFPM1 |
zinc finger protein, multitype 1 |
Mapped by significant region |
|
CFL1 |
cofilin 1 (non-muscle) |
Mapped by significant region |
|
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
Mapped by significant region |
|
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
Mapped by significant region |
|
ADORA2A |
adenosine A2a receptor |
Mapped by CNV |
TAS[10899090]
|
RAB27A |
RAB27A, member RAS oncogene family |
Mapped by LD-proxy |
|
DOCK8 |
dedicator of cytokinesis 8 |
Mapped by CNV |
|
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
Mapped by LD-proxy; Mapped by literature SNP |
|
MGLL |
monoglyceride lipase |
Mapped by PBA pathway |
|
SERPINC1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
Mapped by significant region |
|
KIF23 |
kinesin family member 23 |
Mapped by PBA pathway |
|
CABLES1 |
Cdk5 and Abl enzyme substrate 1 |
Mapped by significant region |
|
SLC3A2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
Mapped by significant region |
|
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
Mapped by CNV |
|
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
Mapped by CNV |
|
SYK |
spleen tyrosine kinase |
Mapped by significant region |
|
APOA1 |
apolipoprotein A-I |
Mapped by significant region |
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
Mapped by significant region |
|
LMAN1 |
lectin, mannose-binding, 1 |
Mapped by LD-proxy; Mapped by PBA pathway; Mapped by significant region |
TAS[9546392]
|
JAM3 |
junctional adhesion molecule 3 |
Mapped by significant region |
|
WDR1 |
WD repeat domain 1 |
Mapped by CNV |
|
KIF2C |
kinesin family member 2C |
Mapped by PBA pathway |
|
SH2B3 |
SH2B adaptor protein 3 |
Mapped by LD-proxy |
|
GUCY1A2 |
guanylate cyclase 1, soluble, alpha 2 |
Mapped by significant region |
|
SLC7A5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
Mapped by significant region |
|
ORAI1 |
ORAI calcium release-activated calcium modulator 1 |
Mapped by PBA pathway |
|
DAGLA |
diacylglycerol lipase, alpha |
Mapped by significant region |
|
SPN |
sialophorin |
Mapped by CNV |
|
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
Mapped by CNV |
|
STXBP3 |
syntaxin binding protein 3 |
Mapped by CNV |
|
TUBA4A |
tubulin, alpha 4a |
Mapped by significant region |
|
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
Mapped by significant region |
|
GATA6 |
GATA binding protein 6 |
Mapped by significant region |
|
KIFC1 |
kinesin family member C1 |
Mapped by LD-proxy |
|
VEGFB |
vascular endothelial growth factor B |
Mapped by significant region |
|
TRPC6 |
transient receptor potential cation channel, subfamily C, member 6 |
Mapped by significant region |
|
ALDOA |
aldolase A, fructose-bisphosphate |
Mapped by CNV |
|
KDM1A |
lysine (K)-specific demethylase 1A |
Mapped by LD-proxy |
|
F2RL2 |
coagulation factor II (thrombin) receptor-like 2 |
Mapped by PBA pathway |
|
PRKAR2B |
protein kinase, cAMP-dependent, regulatory, type II, beta |
Mapped by CNV |
|
BCAR1 |
breast cancer anti-estrogen resistance 1 |
Mapped by significant region |
|
JMJD1C |
jumonji domain containing 1C |
Mapped by PBA pathway |
|
GP1BB |
glycoprotein Ib (platelet), beta polypeptide |
Mapped by CNV |
|
FN1 |
fibronectin 1 |
Mapped by significant region |
|
EHD1 |
EH-domain containing 1 |
Mapped by significant region |
|
PDE2A |
phosphodiesterase 2A, cGMP-stimulated |
Mapped by significant region |
|
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
Mapped by CNV |
|
KIF11 |
kinesin family member 11 |
Mapped by PBA pathway |
|
KLC2 |
kinesin light chain 2 |
Mapped by significant region |
|
F10 |
coagulation factor X |
Mapped by CNV |
IC[17469850]
|
MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
ESAM |
endothelial cell adhesion molecule |
Mapped by significant region |
|
MYB |
v-myb myeloblastosis viral oncogene homolog (avian) |
Mapped by significant region |
|
AKAP10 |
A kinase (PRKA) anchor protein 10 |
Mapped by significant region |
|
PRKCB |
protein kinase C, beta |
Mapped by significant region |
|
POTEKP |
POTE ankyrin domain family, member K, pseudogene |
Mapped by significant region |
|
HABP4 |
hyaluronan binding protein 4 |
Mapped by significant region |
|
PIK3CG |
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
Mapped by CNV |
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
Mapped by significant region |
|
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
Mapped by significant region |
|
HBG2 |
hemoglobin, gamma G |
Mapped by CNV |
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
Mapped by significant region |
|
STX4 |
syntaxin 4 |
Mapped by CNV |
|
YES1 |
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
Mapped by CNV |
|
PRCP |
prolylcarboxypeptidase (angiotensinase C) |
Mapped by significant region |
|
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
Mapped by significant region |
|
EHD3 |
EH-domain containing 3 |
Mapped by CNV |
|
TRPC3 |
transient receptor potential cation channel, subfamily C, member 3 |
Mapped by PBA pathway |
|